: Drugmakers’ deal making will plow ahead despite antitrust scrutiny, analysts say
Big pharma goes shopping as “patent cliff” puts more than $225 billion in revenues at risk.
The 1980s corporate raider claimed poverty for decades — but is now charged with hiding millions in a cannabis company purportedly...
September is shaping up to be a solid month of gains for U.S. stocks, with the market bucking the seasonal...
A reader needs to visualize his retirement buckets to be sure that he has enough.
Rocket Lab USA Inc.’s shares are soaring 12.1% Friday, boosted by KeyBanc Capital Markets’ price-target hike for the space-launch company.
Timing the market with the seasonal “Halloween Indicator.”
One year after the pause on student-loan payments ended, Uncle Sam is getting ready to tell credit-reporting companies which borrowers...